Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway

Fibronectin fibrils regulate TGF-β1-induced Epithelial-Mesenchymal Transition

(2017) Lauren A. Griggs et al.   MATRIX BIOLOGY

Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma

(2017) Xiao-Long Li et al.   Scientific Reports

Integrin beta 1 enhances the epithelial-mesenchymal transition in association with gefitinib resistance of non-small cell lung cancer

(2017) Lixia Ju et al.   Cancer Biomarkers

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer

(2016) T Colangelo et al.   Cell Death & Disease

α-Integrin expression and function modulates presentation of cell surface calreticulin

(2016) C-C Liu et al.   Cell Death & Disease

Calcium homeostasis in cancer: A focus on senescence

(2015) Valerio Farfariello et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer

(2015) Iris Eke et al.   JNCI-Journal of the National Cancer Institute

Role of EGFR expression levels in the regulation of integrin function by EGF

(2015) Daniel Vial et al.   MOLECULAR CARCINOGENESIS

Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition

(2015) Shing-Hwa Liu et al.   Molecular Oncology

Integrin α1β1 expression is controlled by c-MYC in colorectal cancer cells

(2015) S Boudjadi et al.   ONCOGENE

Gli1 promotes transforming growth factor-beta1– and epidermal growth factor–induced epithelial to mesenchymal transition in pancreatic cancer cells

(2015) Qingfeng Liu et al.   SURGERY

Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer

(2015) Iris Eke et al.   JNCI-Journal of the National Cancer Institute

Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer

(2015) Gab-Yong Bae et al.   Oncotarget

The Activation of β1-integrin by Type I Collagen Coupling with the Hedgehog Pathway Promotes the Epithelial-Mesenchymal Transition in Pancreatic Cancer

(2014) Wanxing Duan et al.   CURRENT CANCER DRUG TARGETS

Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases

(2013) Olga Vaksman et al.   HUMAN PATHOLOGY

Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation

(2013) Fei Zhao et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Overexpression of Calreticulin Contributes to the Development and Progression of Pancreatic Cancer

(2013) Weiwei Sheng et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Molecular interactions of ErbB1 (EGFR) and integrin- 1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistance

(2013) M. Petras et al.   NEURO-ONCOLOGY

c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial–mesenchymal transition and invasion in prostate cancer

(2012) Michael D. Amatangelo et al.   CARCINOGENESIS

Epidermal Growth Factor (EGF) Regulates α5β1 Integrin Activation State in Human Cancer Cell Lines through the p90RSK-dependent Phosphorylation of Filamin A

(2012) Daniel Vial et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Collagen/β1 integrin signaling up-regulates the ABCC1/MRP-1 transporter in an ERK/MAPK-dependent manner

(2012) Mohammed-Amine El Azreq et al.   MOLECULAR BIOLOGY OF THE CELL

Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition

(2012) S K Gupta et al.   ONCOGENE

Changes in Tumor Growth and Metastatic Capacities of J82 Human Bladder Cancer Cells Suppressed by Down-Regulation of Calreticulin Expression

(2011) Yi-Chien Lu et al.   AMERICAN JOURNAL OF PATHOLOGY

Calreticulin is crucial for calcium homeostasis mediated adaptation and survival of thick ascending limb of Henle's loop cells under osmotic stress

(2011) Asima Bibi et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Alteration of integrin-dependent adhesion and signaling in EMT-like MDCK cells established through overexpression of calreticulin

(2011) Yoshito Ihara et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Mechanism of the Mesenchymal-Epithelial Transition and Its Relationship with Metastatic Tumor Formation

(2011) D. Yao et al.   MOLECULAR CANCER RESEARCH

β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells

(2011) V Morello et al.   ONCOGENE

Notch1 Expression Predicts an Unfavorable Prognosis and Serves as a Therapeutic Target of Patients with Neuroblastoma

(2010) H.-H. Chang et al.   CLINICAL CANCER RESEARCH

EGF-induced MAPK Signaling Inhibits Hemidesmosome Formation through Phosphorylation of the Integrin β4

(2010) Evelyne Frijns et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Caveolin-1 and integrin β1 regulate embryonic stem cell proliferation via p38 MAPK and FAK in high glucose

(2010) Sang Hun Lee et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Clinicopathological significance of calreticulin in breast invasive ductal carcinoma

(2010) Zin-Mar Lwin et al.   MODERN PATHOLOGY

Epithelial-Mesenchymal Transition in Pancreatic Carcinoma

(2010) Harald J. Maier et al.   Cancers

Calreticulin: non-endoplasmic reticulum functions in physiology and disease

(2009) Leslie I. Gold et al.   FASEB JOURNAL

Identification of Calreticulin as a Prognosis Marker and Angiogenic Regulator in Human Gastric Cancer

(2008) Chiung-Nien Chen et al.   ANNALS OF SURGICAL ONCOLOGY

E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas

(2008) Alan Wells et al.   CLINICAL & EXPERIMENTAL METASTASIS